30 Live Notices for عوامل مضادة للورم
Showing 1 to 20
Oncological Drugs
03 Jul 2024
07 Aug 2024Supplies Of Medicines – Medicinal Substance Enfortumab Vedotin – Atc L01Fx13
Supplies Of Medicinal Products With The Active Ingredient Ribociklib 2024
Itb/2024/52624: Adquisición De Medicamentos Bajo Acuerdos A Largo Plazo Para El Instituto Hondureño De Seguridad Social De Honduras (Ihss) 2024 - 24 Lotes Open New Window
Oncology+General Drugs Framework Agreement
Lp Containing Nivolumab 2024
Framework Agreement Medicines Oncology Programs
Purchase Of Antineoplastic Drugs Pn Oncology And Pn Cost Volume
Medicinal Preparations Containing Cabozantinib
Tender For The Supply Of Ivosidenib, Everolimus And Enforumab Vedotin, No. Competition: F.Y.Y. 74/2024 (Yy), Fax No. F.Y.Y.13.25.02.08.198
Medicinal Preparations Containing Cetuximab
Framework Agreement Medicines Oncology Programs
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
Delivery Of Anticancer Agents, Antifungal Bacterial Agents, Various Medicinal Products, Painkillers, Medicinal Products For Sense Organs, Immune Sera And Immunoglobulins Divided Into 87 Parts.
Acord Cadru Medicamente Programe Oncologie
Medicine Tebentafusp
Miscellaneous Medicines (8)-2024
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Nilotinib (Atc Code: L01Ea03).
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Octreotide, In A Dosage Form With Delayed Release Behavior Atc Code: H01Cb02
Supply Of Buprenorphine (2 Mg) + Naloxone (0.5 Mg) Sublingual Tablet Open New Window
Tenders by Country